Safety of Subcutaneous Immunotherapy in Patients with Severe Asthma. Chow TG, Palka JM, Stone B, Trojan T, et al. Ann Allergy Asthma Immunol 2022 Aug 20. pii: S1081-1206(22)00693.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chow TG, Palka JM, Stone B, Trojan T, et al. Safety of Subcutaneous Immunotherapy in Patients with Severe Asthma. Ann Allergy Asthma Immunol 2022 Aug 20. pii: S1081-1206(22)00693.
PMID: 35998846